Director of Fibrosis, Renal and Cardiovascular Research
Dr. Genovese joined Nordic Bioscience in 2011 and since 2014 has led a group focused on the application of markers for ECM remodeling in renal and cardiovascular disease. Her group's activities range from biomarker discovery and development to clinical and preclinical validation of biomarkers in various chronic kidney diseases (CKD, DKD, IgAN, ADPKD, kidney transplantation) and cardiovascular diseases (HFpEF, atherosclerosis, myocardial infarction, atrial fibrillation).
H-index: 23. i10-index: 39. Citations: 2365
Please don't hesitate to contact us if you have any questions or other inquiries.